Next 10 |
We've got 3 shares up for comparison. Two good choices and one poor choice. You can look at it from different angles, but it still won't look good. Investors are taking more risk for a lower yield. If you're in the wrong share, it would be prudent to upgrade. Get ready for...
We're highlighting a 10% yielder (rounded) set to smash some 13% to 16% yielders. No, it's not NRZ / RITM. I covered that a week ago. We have a different share to highlight this time. Bold Prediction: I'm calling the 10% yielder to outperform four different shares. If this was ran...
We take a look at the action in preferreds and baby bonds through the second week of February and highlight some of the key themes we are watching. The sell-off in the preferreds market has accelerated in February which has now delivered worse performance than all of January. The ...
The global launch of Bylvay was more successful than expected and Albireo doubled its net sales guidance for 2021. Beyond Odevixibat, Albireo was able to discover new drugs with blockbuster. Both early clinical assets address a market with a high medical need and have blockbuster ...
Preferred share opportunities pop up regularly. We called one out yesterday and we’ll mention another today. We’ve got two mortgage REITs that need neutral ratings following a massive share price beatdown. They didn’t plunge from dividend cuts, they were just ...
Mortgage REIT indexes fell by more than 3% midday and closed down more than 2%. The drop, significantly larger than the dip for S&P 500, was not driven by fundamentals. Instead, there were a few factors coming into play. We see opportunities for investors to buy the dip, b...
Part 2 of this article compares ARCC’s recent dividend per share rates, yield percentages, and several other highly unique (and useful) dividend sustainability metrics to 14 BDC peers. This includes a comparative analysis of ARCC’s cumulative undistributed taxable income...
We take a look at the action in BDCs through the first week of December and highlight some of the key themes we are watching. BDCs finished November in the red, in aggregate, with some of the higher-valuation companies underperforming - a typical pro-cyclical valuation pattern. Si...
Part 1 of this article compares ARCC’s recent quarterly change in NAV, quarterly and trailing 24-month economic return, NII, and current valuation to 14 BDC peers. Part 1 also performs a comparative analysis between each company’s investment portfolio as of 6/30/2021 and...
Investors love high yields. Diversification helps, but better investments are even more important. Using two preferred shares we've seen higher yield and lower volatility than PFF. When big dividends come with bigger price changes, many investors hide from reality. For f...
News, Short Squeeze, Breakout and More Instantly...
Prospect Capital Corporation 6.875% Notes due 2029 Company Name:
PBC Stock Symbol:
NYSE Market:
To cater to the increasing demand for specialized cannabis banking skills, PBC has unveiled its Cannabis Banking Certification Program. Historicall...